Bausch Health Companies Inc. (BHC) FY2026 Q2 P&L / Income Statement

Bausch Health Companies Inc. (BHC) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue and costs use their disclosed categories.

Revenues

2,852,000,000 US dollars

Cost of revenue (calculated)

772,000,000 US dollars

Gross profit (calculated)

2,080,000,000 US dollars

Operating expenses (calculated)

1,340,000,000 US dollars

Operating income (loss)

740,000,000 US dollars

Other income (expense), net (calculated)

negative 392,000,000 US dollars

Income (loss) before income taxes

348,000,000 US dollars

Provision for income taxes

88,000,000 US dollars

Net income (loss)

260,000,000 US dollars

Product sales revenue

2,825,000,000 US dollars

Other revenues revenue

27,000,000 US dollars

Product sales cost of revenue

753,000,000 US dollars

Other revenues cost of revenue

19,000,000 US dollars

Selling, general and administrative

907,000,000 US dollars

Research and development

173,000,000 US dollars

Amortization of intangible assets

225,000,000 US dollars

Goodwill impairments

0 US dollars

Restructuring, integration and separation costs

9,000,000 US dollars

Other expense (income), net

26,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Bausch Health Companies Inc.: $258.00 M; to noncontrolling interests: $2.00 M.